haloperidol has been researched along with nalbuphine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schwickerath, J; Wolff, F | 1 |
| Saarialho-Kere, U | 1 |
| Gear, RW; Gordon, NC; Lee, JS; Levine, JD; Miaskowski, C; Paul, SM | 1 |
1 review(s) available for haloperidol and nalbuphine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for haloperidol and nalbuphine
| Article | Year |
|---|---|
Psychomotor, respiratory and neuroendocrinological effects of nalbuphine and haloperidol, alone and in combination, in healthy subjects.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Drug Interactions; Female; Haloperidol; Humans; Male; Morphinans; Nalbuphine; Neurosecretory Systems; Psychomotor Performance; Random Allocation; Respiration; Respiratory Function Tests | 1988 |
Neuroleptics antagonize nalbuphine antianalgesia.
Topics: Analgesics, Opioid; Chlorpromazine; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Nalbuphine; Narcotic Antagonists; Pain Measurement; Pain, Postoperative; Sex Factors; Tooth Extraction | 2006 |
6 other study(ies) available for haloperidol and nalbuphine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
[Opiate analgesia in labor--use of nalbuphine in comparison with administration of the combination Dolantin/Atosil/Haldol].
Topics: Analgesia, Obstetrical; Drug Therapy, Combination; Extraction, Obstetrical; Female; Haloperidol; Humans; Infant, Newborn; Injections, Intramuscular; Maternal-Fetal Exchange; Meperidine; Nalbuphine; Pain Measurement; Pregnancy; Pregnancy Outcome; Promethazine; Uterine Contraction | 1991 |